The National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program allows eligible patients to access free National Immunisation Program (NIP) vaccines in a community pharmacy, with no out-of-pocket costs.
The NIPVIP Program will commence on 1 January 2024, with program registration and claiming available in the PPA Portal from this date.
Participating pharmacies can receive a payment of $18.85 per vaccination for the administration of National Immunisation Program (NIP) vaccines in a pharmacy setting, for individuals aged 5 years and over. The NIP vaccines that can be administered by pharmacies are determined by state and territory legislation.
The PPA Portal also provides the following program information:
|Links to pharmacist vaccination standards/codes/protocols/supply arrangements and relevant guidelines
The vaccination legislation and regulation for vaccination in community pharmacy differs for each state and territory including the types of vaccines that can be administer, who is authorised to administer vaccines and the minimum age for patients receiving a vaccine.
Since well before the publication of the Community Pharmacy Roadmap in May 2010 the Guild has been actively working on expanding pharmacists professional activities in the delivery of services to improve the health outcomes of all Australians. The Guild has always seen pharmacist vaccination as an opportunity for innovation in community pharmacy health service delivery.
On 5 December 2013, the Pharmacy Board of Australia announced that vaccination was within the current scope of practice of pharmacists. This statement followed work undertaken on its behalf by the then Advanced Pharmacy Practice Framework Steering Committee and with consultation with the Guild.
The Queensland Pharmacist Immunisation Pilot (QPIP) Phase 1 operated from 1 April 2014 to 30 September 2014 in 80 pharmacies and saw 10,889 influenza vaccines delivered, demonstrating that community pharmacy is well placed to improve vaccination rates. Almost one in five people vaccinated in the QPIP Phase 1 trial had indicated that they would not otherwise have been vaccinated and one in seven said it was the first time they had been vaccinated for influenza. The QPIP Phase 2 trial operated from March 2015 to April 2016 and was expanded to include measles and pertussis in 200 pharmacies.
Since early 2015, appropriately trained pharmacists in South Australia and Western Australia have been administering approved vaccines. Since 2016, appropriately trained pharmacists in Tasmania, ACT, NSW, QLD and Victoria can administer approved vaccines